TABLE 1.
Criteria | Determinants |
Problem | Anecdotal data suggests that MET, a drug used to treat type II diabetes mellitus, affects the ability of macrophages to control intracellular Mtb. |
Intervention | Does MET affect the ability of macrophages to control intracellular Mtb. |
Comparison | Absence of MET. |
Outcomes | Effect on macrophage phagolysosomal activity. |
Synergistic effect with current TB therapy. | |
Study setting | Includes studies worldwide. |
MET, metformin; Mtb, Mycobacterium tuberculosis; PICOS, Population/Problem, Intervention, Comparison, Outcomes and Study setting; TB, tuberculosis.